Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Charles Cazanave

ResearcherPublications, citations & collaboration network

Charles Cazanave is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 281 works, 6,946 citations, an h-index of 38 and an i10-index of 98.

281
Works
6,946
Citations
38
h-index
98
i10-index

How has Charles Cazanave's publication output changed over time?

ScholarIQpublication output · 2008–2022

Output grew0% over the shown period — from 2 works in 2008 to 2 in 2022.

2
1
1
1
2
2
2
2008200920122013201720212022

What are the most-cited papers on Charles Cazanave?

ScholarIQmost cited works
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Adam Trickey, Margaret May, Jörg Janne Vehreschild, Niels Obel, M. John Gill, Heidi M. Crane, Christoph Boesecke, Sophie Patterson, Sophie Grabar, Charles Cazanave, Matthias Cavassini, Leah Shepherd, Antonella d’Arminio Monforte, Ard van Sighem, M. S. Saag, Fiona Lampe, Vicky Hernando, Marta Montero, Robert Zangerle, Amy C. Justice, Timothy R. Sterling, Suzanne M Ingle, Jonathan A C Sterne
S2531945440. 20171,112 CitationsOPEN ACCESS
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients
Stéphane De Wit, Caroline Sabin, Rainer Weber, Signe Westring Worm, Peter Reiss, Charles Cazanave, Wafaa El‐Sadr, Antonella d’Arminio Monforte, Éric Fontas, Matthew Law, Nina Friis‐Møller, Andrew Phillips
Diabetes Care. 2008480 CitationsOPEN ACCESS
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Hongchao Pan, Richárd Pető, Ana María Henao-Restrepo, Marie‐Pierre Préziosi, Vasee Moorthy, Quarraisha Abdool Karim, Marissa Alejandria, César Hernàndez García, Marie-Paule Kiény, Reza Malekzadeh, Srinivas Murthy, K. Srinath Reddy, Mirta Roses Periago, Pierre Abi Hanna, Akaki Abutidze, Florence Ader, Abdullah Al-Bader, Almonther Alhasawi, Emma Allum, Adhra Al‐Mawali, Athari Alotaibi, Carlos Álvarez, Sheila Appadoo, Derk L. Arts, Abdullah M. Asiri, Pål Aukrust, Andreas Barratt‐Due, Abebe Genetu Bayih, H. Beaumont, Samir Bellani, Virginia Benassi, Balram Bhargava, Mattia Branca, Heike Cappel-Porter, Nery Cerrato, Fadima Cheick Haidara, Ting Soo Chow, Nadia Como, Joe Eustace, Tamar Gabunia, Patricia García, Sheela Godbole, Eduardo Gotuzzo, Laimonas Griškevičius, Rasha Hamra, Mariam Hassan, Mohamed Hassany, David W. Hutton, Irmansyah Irmansyah, Ligita Jančorienė, Faryal Khamis, Jana Kirwan, Suresh Kumar, Peter Lennon, Gustavo Lopardo, Patrick Lydon, Nicola Magrini, Suzana Manevska, Oriol Manuel, Sybil McGinty, Marco T. Medina, María Lucía Mesa Rubio, María Consuelo Miranda, Jeremy Nel, Estêvão Portela Nunes, Markus Perola, Antonio Portolés, Menaldi Rasmin, Aun Raza, Helen Rees, Paula Reges, Chris Rogers, Kolawole Salami, Marina I. Salvadori, Mamatha Sauermann, Narvina Sinani, Samba O. Sow, Jonathan A C Sterne, Milena Stevanoviкј, Evelina Tacconelli, Fernando Maltêz, Mekonnen Teferi, Kari A.O. Tikkinen, Sven Trelle, Tengiz Tsertsvadze, Hala Zaid, John-Arne Røttingen, Soumya Swaminathan, Michael P. Ryan, Nevila Gjermeni, Esmeralda Meta, Damián Águila, Ignacio Alonso, Marcos Altamirano, María López Álvarez, Rodrigo Alzola, Verónica Arce, Patricia Arribillaga, Rafael Ávila, Juan Pablo Balbuena
The Lancet. 2022406 CitationsOPEN ACCESS
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Florence Ader, Florence Ader, Maude Bouscambert-Duchamp, Maya Hites, Nathan Peiffer-Smadja, Julien Poissy, Drifa Belhadi, Alpha Diallo, Minh-Patrick Lê, Gilles Peytavin, Thérèse Staub, Richard Greil, Jérémie Guedj, Jose-Artur Paiva, Dominique Costagliola, Yazdan Yazdanpanah, Charles Burdet, France Mentré, Alexander Egle, Richard Greil, Michael Joannidis, Bernd Lamprecht, Antoine Altdorfer, Leïla Belkhir, Vincent Fraipont, Maya Hites, Gil Verschelden, Jérôme Aboab, Florence Ader, Florence Ader, Hafid Ait‐Oufella, Claire Andréjak, Pascal Andreu, Laurent Argaud, Firouzé Bani‐Sadr, François Bénézit, Mathieu Blot, Élisabeth Botelho-Nevers, Lila Bouadma, Olivier Bouchaud, David Bougon, Kévin Bouiller, Fanny Bounes-Vardon, David Boutoille, Alexandre Boyer, Cédric Bruel, André Cabie, Emmanuel Canet, Charles Cazanave, Cyrille Chabartier, Catherine Chirouze, Raphaël Clère-Jehl, Johan Courjon, Flora Crockett, François Danion, Agathe Delbove, Jean Dellamonica, Félix Djossou, C Dubost, Alexandre Duvignaud, Olivier Épaulard, Loïc Epelboin, Murielle Fartoukh, Karine Faure, Emmanuel Faure, Tristan Ferry, C. Ficko, Samy Figueiredo, Benjamin Gaborit, Rostane Gaci, Amandine Gagneux‐Brunon, Sébastien Gallien, Denis Garot, Guillaume Géri, Sébastien Gibot, François Goehringer, Marie Gousseff, Didier Gruson, Yves Hansmann, O. Hinschberger, Stéphane Jauréguiberry, Vanessa Jean-Michel, Solen Kernéis, Antoine Kimmoun, Kada Klouche, Marie Lachâtre, Karine Lacombe, Fabrice Laine, Jean‐Philippe Lanoix, Odile Launay, Bruno Laviolle, Vincent Le Moing, Jérôme Le Pavec, Yves Le Tulzo, Paul Le Turnier, David Lebeaux, Benjamin Lefèvre, Sylvie Leroy, François‐Xavier Lescure, Henry Lessire
S23772524. 2021344 CitationsOPEN ACCESS
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
François-Xavier Lescure, Hitoshi Honda, Robert Fowler, Jennifer Sloane Lazar, Genming Shi, Peter K. Wung, Naimish Patel, Owen Hagino, Ignacio J. Bazzalo, Marcelo Martín Casas, Sebastián A. Núñez, Yael Pere, Carlos M. Ibarrola, Marco A. Solis Aramayo, María Celia Cuesta, Andrea E. Duarte, Pablo Fernández, Maria A. Iannantuono, Erica A. Miyazaki, Javier P. Silvio, Darío Scublinsky, Alessandra Martins Bales, Daniela Catarino, Elie Fiss, Sara Mohrbacher, Victor Augusto Hamamoto Sato, Antonio Baylao, Adilson W. Cavalcante, Francini Guerra Correa, Celso A. de Andrade, Juvêncio José Duailibe Furtado, Nelson Ribeiro Filho, Valéria Telles, Leopoldo Tosi Trevelin, Ricardo Vipich, Rodrigo Boldo, Paula Borges, Suzana M. Lobo, Graziela Denardin Luckemeyer, Luana Machado, Maysa B. Alves, Ana Caroline Coutinho Iglessias, Marianna M. Lago, Daniel Wagner de Castro Lima Santos, Hugo Chapdelaine, Emilia Liana Falcone, Rahima Jamal, Me‐Linh Luong, Madéleine Durand, Stéphane Doucet, François Martin Carrier, Bryan Coburn, Lorenzo Del Sorbo, Sharon Walmsley, Sara Belga, Luke Y. C. Chen, Allison Mah, Theodore S. Steiner, Alissa Wright, J Hájek, Neill K. J. Adhikari, Robert Fowler, Nick Daneman, Kosar Khwaja, Jason Shahin, Carolina González, Rafael Silva, Marcelo Lindh, Gabriel Maluenda, Patricia Fernández, Maite Oyonarte, Martín Lasso, Alexandre Boyer, Didier Brönnimann, Hoang-Nam Bui, Charles Cazanave, H. Chaussade, Arnaud Desclaux, M. Ducours, Alexandre Duvignaud, Denis Malvy, Lisa J. Martin, D. Neau, Duc Thanh Nguyen, Thierry Pistone, Gaetane Soubrane-Wirth, Julie Leitao, Clotilde Allavena, Charlotte Biron, Sabelline Bouchez, Benjamin Gaborit, Antoine Grégoire, Paul Le Turnier, Anne-Sophie Lecompte, R. Lecomte, M. Lefèbvre, F. Raffi, David Boutoille, P Morineau, Romain Guéry
The Lancet Respiratory Medicine. 2021248 CitationsOPEN ACCESS

Related on ScholarIQ

Centre National de la Recherche Scientifique
Institution
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Paper
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients
Paper
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Paper
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Paper
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
Paper
470M+ articles · free account